Editorial highlights updated guidance on labeling for biosimilars
Labeling recommendations now include interchangeable biosimilar products
Labeling recommendations now include interchangeable biosimilar products
Comments on barriers and enablers will be used to advance innovation
Webinar focuses on updates to reduce common SEND errors
Learn how the agency uses science and data to ensure drug safety, quality and efficacy
Event to also highlight preparations for AI technologies
Software could help people take medication more safely, effectively
PSAs inform consumers about the safe use and disposal of FDA-regulated products
The agency and HHS are working together to address the public health emergency
New initiative supports delivery of treatments for patients with a rare disease
Your source for the latest drug information.
Know the moment it happens.